CLINICAL TRIALS & RESEARCH
Our Work

Representation in Research

Representation in Research

Ideally, the participant populations enrolled in clinical trials reflect the populations of those affected by the disease or condition for which the investigational product is being tested. However, despite regulatory directives and public expectations, there remain populations that are underrepresented in clinical trials, such as women, different ethnic and racial groups, sexual and gender minorities, people living with disabilities, the elderly, and people living in rural areas. The failure to achieve appropriate representation limits both generalizable and sub-group-specific information about drug response and measures of safety and efficacy.

The MRCT Center’s Representation in Clinical Research program began in 2018 to address this challenge, publishing the Achieving Diversity, Inclusion, Equity in Clinical Research Guidance Document and Toolkit in 2020, the IRB and HRPP [DEI] Toolkit in 2022, and the Accessibility by Design in Clinical Research Toolkit in 2023. While significant progress has been made in the last few years, through the dedicated commitment and foundational work of many stakeholders across the clinical research enterprise, we remained attuned to that which we still need to learn, and actions we need to take so the future of health equity and justice look different compared to today.

DEI people DEI people DEI people DEI people DEI people DEI people DEI people DEI people DEI people
Global populations/People living outside the US Resources for IRB/HRPP members Resources for IRB/HRPP members Limited English Proficiency (LEP) populations Disabled populations/People with disabilities Disabled populations/People with disabilities Disabled populations/People with disabilities LGBTQIA+ populations LGBTQIA+ populations Financially challenged and underinsured populations Financially challenged and underinsured populations Financially challenged and underinsured populations Underrepresented Populations in General Underrepresented Populations in General Underrepresented Populations in General Disabled populations/People with disabilities Disabled populations/People with disabilities Disabled populations/People with disabilities with disabilities

Objectives

  • Advance the goal of diverse representation of participants in clinical research by developing conceptual and methodological frameworks to advance the understanding of, and accountability for, diverse representation in clinical trials;
  • Review current methods and guidance used to define, collect, analyze, utilize, and communicate clinical trial data on race, ethnicity, sex, gender identity, sexual orientation, age, disability, and other factors;
  • Describe the barriers to diverse representation in research in the U.S. and in multi-regional trials, including scientific, ethical, and sociopolitical challenges; and generate and share lessons learned about potential approaches for effective communication, recruitment, and retention of underrepresented participants;
  • Support engagements and sustainable partnerships with community advocates, organizations, and referring providers, and diverse workforce development of clinical research personnel;
  • Develop and disseminate actionable and scalable solutions (“tools”) to support the inclusion of diverse populations in research.

Key Milestones

Project Leadership & Staff

  • Willyanne DeCormier Plosky, Program Director, MRCT Center
  • Hayat Ahmed, Program Manager, MRCT Center
  • Barbara Bierer, Faculty Director, MRCT Center

Project Resources